Guideline manuscript template conformation to reporting checklists
| Domain . | GIN-McMaster checklist (step) . | RIGHT (topic) . | AGREE II (item) . | Guideline manuscript template (page)* . |
|---|---|---|---|---|
| Basic information | ||||
| Title | — | 1 | — | 1 |
| Authors | 15.3 | — | — | 1 |
| Abstract | — | — | — | 2 |
| Executive summary | — | 2 | 17 | 3 |
| Abbreviations and acronyms | — | 3 | — | 1 |
| Corresponding developer | — | 4 | — | 1 |
| Background | ||||
| Brief description of the health problem | 2.9 | 5 | — | 6 |
| Aims of the guideline and specific objectives | 2.2 | 6 | 1 | 6 |
| Target populations | 8.3, 8.7 | 7 | 2 & 3 | 6 |
| End users and settings | 5 | 8 | 6 | 6 |
| Guideline development groups | 3 | 9 | 4 | 7 |
| Evidence | ||||
| Health care questions | 8 | 10 | 2 | 9 |
| Systematic reviews | 10, 11 | 11 | 7, 8 | 9 |
| Assessment of the certainty of the body of evidence | 12 | 12 | 9 | 10 |
| Recommendations | ||||
| Recommendations | 13 & 14 | 13 | 10, 11, 15, 16, 20 | 13 |
| Rationale for recommendations | 13.6 | 14 | 5, 12, 20 | 13 |
| Evidence to decision process | 13.1 | 15 | 10, 12 | 9 |
| Review and quality assurance | ||||
| External review | 15.7, 15.8 | 16 | 13 | 12 |
| Quality assurance | 15.6 | 17 | — | 12 |
| Funding and declaration and management of interests | ||||
| Funding sources and roles of the funder | 7.6 | 18 | 22 | 7 |
| Declaration and management of interests | 7 | 19 | 23 | 7 |
| Other information | ||||
| Access | 16.1 | 20 | — | Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) |
| Suggestions for further research | 13.5 | 21 | — | Each recommendation (EtD) |
| Limitations of the guideline | — | 22 | — | 15 |
| Updating the guideline | 18 | — | 14 | 16 |
| Applicability | 14.5 | 14 | 14 | Whole document (eg, feasibility, barriers for each recommendation) |
| Implementation | 16 | — | 18, 19 | Each recommendation (EtD) & 16 (local adaptation) |
| Monitoring | 17.3 | — | 21 | Each recommendation (EtD) |
| Domain . | GIN-McMaster checklist (step) . | RIGHT (topic) . | AGREE II (item) . | Guideline manuscript template (page)* . |
|---|---|---|---|---|
| Basic information | ||||
| Title | — | 1 | — | 1 |
| Authors | 15.3 | — | — | 1 |
| Abstract | — | — | — | 2 |
| Executive summary | — | 2 | 17 | 3 |
| Abbreviations and acronyms | — | 3 | — | 1 |
| Corresponding developer | — | 4 | — | 1 |
| Background | ||||
| Brief description of the health problem | 2.9 | 5 | — | 6 |
| Aims of the guideline and specific objectives | 2.2 | 6 | 1 | 6 |
| Target populations | 8.3, 8.7 | 7 | 2 & 3 | 6 |
| End users and settings | 5 | 8 | 6 | 6 |
| Guideline development groups | 3 | 9 | 4 | 7 |
| Evidence | ||||
| Health care questions | 8 | 10 | 2 | 9 |
| Systematic reviews | 10, 11 | 11 | 7, 8 | 9 |
| Assessment of the certainty of the body of evidence | 12 | 12 | 9 | 10 |
| Recommendations | ||||
| Recommendations | 13 & 14 | 13 | 10, 11, 15, 16, 20 | 13 |
| Rationale for recommendations | 13.6 | 14 | 5, 12, 20 | 13 |
| Evidence to decision process | 13.1 | 15 | 10, 12 | 9 |
| Review and quality assurance | ||||
| External review | 15.7, 15.8 | 16 | 13 | 12 |
| Quality assurance | 15.6 | 17 | — | 12 |
| Funding and declaration and management of interests | ||||
| Funding sources and roles of the funder | 7.6 | 18 | 22 | 7 |
| Declaration and management of interests | 7 | 19 | 23 | 7 |
| Other information | ||||
| Access | 16.1 | 20 | — | Whole document (eg, citation to guideline, links to EtDs with evidence profiles, and supplements) |
| Suggestions for further research | 13.5 | 21 | — | Each recommendation (EtD) |
| Limitations of the guideline | — | 22 | — | 15 |
| Updating the guideline | 18 | — | 14 | 16 |
| Applicability | 14.5 | 14 | 14 | Whole document (eg, feasibility, barriers for each recommendation) |
| Implementation | 16 | — | 18, 19 | Each recommendation (EtD) & 16 (local adaptation) |
| Monitoring | 17.3 | — | 21 | Each recommendation (EtD) |
Supplement 1; —, not addressed.